Table 3 Population coverage by selected MHC class-I epitopes
From: In silico multi-epitope Bunyumwera virus vaccine to target virus nucleocapsid N protein
Population | Coverage |
|---|---|
World | 89.42% |
East Asia | 86.88% |
North East Asia | 65.36% |
South East Asia | 72.63% |
South West Asia | 73.06% |
Europe | 96.21% |
East Africa | 74.33% |
West Africa | 68.23% |
Central Africa | 63.13% |
North Africa | 72.24% |
South Africa | 53.38% |
North America | 88.61% |